Cancer Biology and Oncology
A section of Biomedicines (ISSN 2227-9059).
Section Information
Scope
This section publishes reviews and original peer-reviewed papers of a high scientific standard, covering all the aspects of innovative cancer therapies. Papers aim to uncover novel therapeutic approaches toward overcoming conventional anticancer drug resistance, a better understanding of the interrelations between cancer and metabolism as well as tumor and microenvironment, along with the discovery of novel diagnostic and prognostic makers. Topics include but are not limited to in vitro and in vivo cancer therapeutic responses, targeted therapies (including metabolism and immunotherapy, such involving CAR-T cells), identification of novel therapeutic targets, and evaluation of novel diagnosis and prognosis markers and the assessment of their impact on morphological, phenotypical, and molecular classifications.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in Therapeutic Strategies in Gynecological Malignant Tumors—2nd Edition (Deadline: 30 November 2024)
- Histiocytosis and Treatment Targets (Deadline: 30 November 2024)
- Diagnostics and Therapy for Malignant Tumors: New Developments (Deadline: 30 November 2024)
- The Role Precision Medicine in the Field of Cancer Oncology (Deadline: 30 November 2024)
- Recent Advances in Primary and Relapsed Ovarian Cancer (Deadline: 30 November 2024)
- New Insights into Upper Tract Urothelial Carcinoma: What Changed? (Deadline: 30 November 2024)
- Molecular and Pharmacological Basis of Breast Cancer Resistance to Therapies (Deadline: 30 November 2024)
- New Insights into Breast Cancer Management: From Tumorigenesis to Personalized Treatments (Deadline: 30 November 2024)
- Advancing Cancer Immunotherapy: Unleashing the Potential of the Immunological Synapse (Deadline: 30 November 2024)
- Mesenchymal Tumors of the Liver: From Basic Research to New Therapies (Deadline: 30 November 2024)
- Killing It Softly–New Approaches to Overcome Cancer Chemoresistance 2.0 (Deadline: 15 December 2024)
- The Biology of Circulating Tumor Cells 2.0 (Deadline: 15 December 2024)
- Unraveling the Role of Glucocorticoid Receptor in Inflammation and Cancer (Deadline: 15 December 2024)
- Immunotherapy for Urothelial Carcinoma: Milestones and Future Horizons (Deadline: 20 December 2024)
- MicroRNAs as Mediators of Tumor Cell State Transitions, Receptor Remodeling, Drug Resistance, and Systemic Metastasis (Deadline: 31 December 2024)
- Advances in Cancer Biology and Experimental Anticancer Therapies (2nd Edition) (Deadline: 31 December 2024)
- Novel Progress in Cancer Immunotherapy (Deadline: 31 December 2024)
- Extracellular Vesicles in Cancer Progression and Therapeutic Response (Deadline: 31 December 2024)
- Personalized Medicine in Cancer Treatment: Apoptosis, Autophagy, and Drug Selection (Deadline: 31 December 2024)
- Pancreatic Cancer: From Mechanisms to Therapeutic Approaches (3rd Edition) (Deadline: 31 December 2024)
- Hepato-Pancreato-Biliary Cancers: Pathogenesis, Comorbidities and Therapy Updated (Deadline: 31 December 2024)
- Drug Resistance and Novel Targets for Cancer Therapy—Second Edition (Deadline: 31 December 2024)
- Multidisciplinary Management of Rare Head and Neck Tumors: The Importance of Knowing and Dealing with Them (Deadline: 31 December 2024)
- New Insights into the Diagnosis and Treatment of Breast Cancer (Deadline: 31 December 2024)
- Resistance to Targeted Therapies in Human Cancer, 2nd Edition (Deadline: 31 December 2024)
- The Role of NK Cells in Health and Diseases (Deadline: 15 January 2025)
- Novel Targets for Breast Cancer (Deadline: 31 January 2025)
- Role of Bone Marrow Niche in Haematological Cancers (Deadline: 31 January 2025)
- Mechanisms and Novel Therapeutic Approaches for Gliomas (Deadline: 31 January 2025)
- Drug Resistance and Tumor Microenvironment in Human Cancers (Deadline: 31 January 2025)
- Targeting the Resistant Tumor Microenvironment in Lymphoma: From Basic Science to Artificial Intelligence (Deadline: 31 January 2025)
- The Role of Environmental Pollutants in Cancer and Chemoresistance (Deadline: 31 January 2025)
- Peptide Therapeutic Approaches for Cancer Treatment (Deadline: 31 January 2025)
- Mechanisms and Therapeutic Approaches for Hepatocellular Carcinoma (Deadline: 31 January 2025)
- Novel Approaches towards Targeted Head and Neck Cancer Therapies (Deadline: 31 January 2025)
- Breast Cancer: New Diagnostic and Therapeutic Approaches (Deadline: 31 January 2025)
- Personalized Treatment in Cancer Research (Deadline: 31 January 2025)
- Extracellular Vesicles: Research Advances in Cancer Treatment and Diagnostics (Deadline: 31 January 2025)
- Targeted Therapies for Cancers (Deadline: 28 February 2025)
- Advances in Immunotherapy and Radiation Therapy for Cancer (Deadline: 28 February 2025)
- Feature Reviews in Precision Oncology (Deadline: 28 February 2025)
- Roles of Extracellular Vesicles in Cancer Immunotherapy (Deadline: 28 February 2025)
- Advancements in Artificial Intelligence (AI) for Cancer Genomics and Genetics (Deadline: 28 February 2025)
- Hepatocellular Carcinoma Pathogenesis and Therapy (Deadline: 28 February 2025)
- Two Decades of Progress in the Prevention and Treatment of Colorectal Cancer: From Aspirin to Targeted Therapy (Deadline: 28 February 2025)
- Advanced Cancer Diagnosis and Treatment: Second Edition (Deadline: 28 February 2025)
- Pathogenesis, Disease Detection and Novel Therapeutic Approaches for Osteosarcoma (Deadline: 28 February 2025)
- Advancements in Lung Cancer Precision Oncology Research and Treatments (Deadline: 28 February 2025)
- An Update on Mechanisms and Treatments for Thyroid Cancer in Current Oncology (Deadline: 28 February 2025)
- Advances in Liver Oncology: Molecular Mechanisms and Therapeutic Innovations (Deadline: 31 March 2025)
- Head and Neck Cancer: From Immunotherapy Treatments to New Drug Combinations (Deadline: 31 March 2025)
- Novel Insights into Diagnosis and Therapy of Advanced Renal Cell Carcinoma (Deadline: 31 March 2025)
- Oral Squamous Cell Carcinoma: Molecular Signaling Pathways and Novel Biomarkers (Deadline: 31 March 2025)
- Molecular Research and New Therapy in Melanoma (Deadline: 31 March 2025)
- Mitochondria and Immunometabolism in Cancer (Deadline: 31 March 2025)
- Head and Neck Tumors, 4th Edition (Deadline: 31 March 2025)
- New Insights into the Diagnosis and Treatment of Hepatocellular Carcinoma (Deadline: 31 March 2025)
- The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances (Deadline: 31 March 2025)
- Prostate Cancer Management: Current Challenges, Emerging Therapies, and Men's Health Implications (Deadline: 31 March 2025)
- Recent Advances in Gastrointestinal Cancers: From Microbiota Modulation to New Therapeutic Approaches (Deadline: 31 March 2025)
- Urogenital Cancers: New Molecular and Translational Aspects on Carcinogenesis and Treatments (Deadline: 31 March 2025)
- Prostate Cancer Targeted Therapy: Highlighting Advances in Precision Medicine and Rational Combination Approaches (Deadline: 31 March 2025)
- Advanced Research in Epithelial–Mesenchymal Transition (EMT) in Cancers (Deadline: 31 March 2025)
- Navigating the Tumor Microenvironment: The Role of Reactive Oxygen Species in Cancer Progression and Therapy (Deadline: 30 April 2025)
- Malignant and Potentially Malignant Disorders of the Oral Cavity: Updates from Pathogenesis to Therapy 2.0 (Deadline: 30 April 2025)
- Chemoprevention to Dwindle Tumor Development (Deadline: 30 April 2025)
- The Role of HOX Genes in Particular Cancers (Deadline: 30 April 2025)
- Hepatocellular Carcinoma: From Pathophysiology to Therapeutic Approaches Treatment (Deadline: 30 April 2025)
- Past, Present and Further Looking for Therapeutic Management of Pancreatic Ductal Adenocarcinoma (2nd Edition) (Deadline: 30 April 2025)
- Mechanisms and Novel Treatment Options for Non-Small-Cell Lung Cancer (Deadline: 30 April 2025)
- The Development of Cancer Immunotherapy (Deadline: 30 April 2025)
- Thoracic Malignancies: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 April 2025)
- Molecular Mechanisms of Myeloid Cell Differentiation and Resistance to Anti-Tumor Immunity (Deadline: 30 April 2025)
- Novel Approaches for Diagnosis and Treatment of Pancreatic Cancer (Deadline: 30 April 2025)
- Diagnosis, Pathogenesis and Treatment of Pancreatic Ductal Adenocarcinoma (Deadline: 30 April 2025)
- From Bench to Bedside: Advances in Non-small Cell Lung Cancer in the Era of Precision Oncology (Deadline: 30 April 2025)
- Targeting Transcription Factors and Oncogenic Proteins for Cancer Therapy (2nd Edition) (Deadline: 30 April 2025)
- Advances in the Treatment of Kidney and Upper Urinary Tract Cancers: Second Edition (Deadline: 30 April 2025)
- NASH and Hepatocellular Carcinoma (HCC) (Deadline: 30 April 2025)
- Advances in the Pharmacology of Neuroendocrine Tumors (Deadline: 30 April 2025)
- Head-and-Neck Sarcomas: Exploring Ways for Their Optimal Treatment (Deadline: 30 April 2025)
- Endocrine Cancers: Pathophysiology and Therapy (Deadline: 30 April 2025)
- CDK Inhibitors: A New Wave of Therapeutic Agents for Human Diseases (Deadline: 31 May 2025)
- Advances of Autophagy in Human Cancers and Tumors (Deadline: 31 May 2025)
- Genomic Insights and Translational Opportunities for Human Cancers (Deadline: 31 May 2025)
- Antibody–Drug Conjugates and Cancer Immunotherapy (Deadline: 31 May 2025)
- Prostate Cancer: From Pathology to Novel Therapeutic Approaches (2nd Edition) (Deadline: 31 May 2025)
- Colorectal Cancer: Diagnostic, Pathophysiology and Therapeutic Approaches (Deadline: 31 May 2025)
- Triple Negative Breast Cancer: From Mechanisms to Therapeutic Approaches (Deadline: 30 June 2025)
- Novel Strategies for Oncogene-Addicted Lung Cancers: Not Rare Anymore (Deadline: 31 July 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Autophagy in Cancer and Metastasis
- Feature Papers in Cancer Biology and Therapeutics
- Hereditary Gastrointestinal Cancer Syndromes: Molecular Basis of Onset and Progression, Molecular Diagnosis, and Precision Therapy
- Stem Cells and Cancer Therapeutics (Closed)
- Targeting Cell Metabolism as Cancer Therapy (Closed)
